Botulinum toxin is a zinc-dependent endoprotease that acts on vulnerable cells to cleave polypeptides that are essential for exocytosis. To exert this poisoning effect, the toxin must proceed through a complex sequence of events that involves binding, productive internalization, and intracellular expression of catalytic activity. Results presented in this study show that soluble chelators rapidly strip Zn 2؉ from its binding site in botulinum toxin, and this stripping of cation results in the loss of catalytic activity in cell-free or broken cell preparations. Stripped toxin is still active against intact neuromuscular junctions, presumably because internalized toxin binds cytosolic Zn 2؉ . In contrast to soluble chelators, immobilized chelators have no effect on bound Zn 2؉ , nor do they alter toxin activity. The latter finding is because of the fact that the spontaneous loss of Zn 2؉ from its coordination site in botulinum toxin is relatively slow. When exogenous Zn 2؉ is added to toxin that has been stripped by soluble chelators, the molecule rebinds cation and regains catalytic and neuromuscular blocking activity. Exogenous Zn 2؉ can restore toxin activity either when the toxin is free in solution on the cell exterior or when it has been internalized and is in the cytosol. The fact that stripped toxin can reach the cytosol means that the loss of bound Zn 2؉ does not produce conformational changes that block internalization. Similarly, the fact that stripped toxin in the cytosol can be reactivated by ambient Zn 2؉ or exogenous Zn 2؉ means that productive internalization does not produce conformational changes that block rebinding of cation.
Botulinum toxin poisons vulnerable cells by proceeding through a sequence of three major steps: binding, productive internalization, and intracellular expression of catalytic activity (1) . Each of the three major steps in toxin action can be further subdivided into two or more events. Thus, the binding step reportedly involves two sequential processes. During the first, toxin associates with low affinity receptors on the cell surface, and during the second, the low affinity complex shuttles the toxin to a high affinity receptor (2) . Productive internalization also involves a number of events (see "Discussion"), with the two major ones being receptor-mediated endocytosis across the plasma membrane and pH-dependent translocation across the endosome membrane. During the final step, botulinum toxin acts as a zinc-dependent endoprotease to cleave polypeptides that govern exocytosis (3) . Enzymatic cleavage of these polypeptides must also involve multiple events (viz. substrate binding, substrate cleavage), although this has not been studied extensively.
During the interval since toxin action was first described as a sequence of three steps (4, 5) , investigators have tended to examine these steps as though they are separate and independent. However, recent and apparently contradictory findings may necessitate a change in perspective. In 1992, Schiavo et al. (6) and Link et al. (7) reported that botulinum toxin type B and tetanus toxin were zinc-dependent endoproteases. In 1993, Simpson et al. (8) reported that all seven botulinum toxin serotypes (A-G) were likely to be zinc-dependent endoproteases, because the toxicity of all seven serotypes was diminished by zinc chelation. However, the work with Zn 2ϩ chelators revealed an unexpected outcome. It was observed that removing Zn 2ϩ from toxin was necessary but not sufficient to cause a loss of toxicity against intact cells. Toxin stripped of Zn 2ϩ could still produce blockade of exocytosis, apparently because the toxin could replenish its divalent cation from tissue stores. In keeping with this idea, the chelation of toxin as well as tissue was necessary to produce marked reductions in toxin activity.
More recently, Fu et al. (9) have published findings that seem to contradict those just described. They found that the use of a chelator to remove Zn 2ϩ from toxin led to irreversible changes in tertiary structure as measured by various light-scattering techniques. They also found that removal of the cation led to irreversible losses in toxicity as measured by norepinephrine release from permeabilized PC-12 cells.
Close inspection of these contradictory findings on Zn 2ϩ reveals that there could be implications that extend beyond the final or catalytic step in toxin action. These data may also have an impact on proposed models for productive internalization and particularly on models for toxin penetration of the endosome membrane (see "Discussion"). Thus, any model that calls for a significant relaxation of the toxin molecule, which in turn could cause the loss of Zn 2ϩ binding, would not be plausible unless the toxin could subsequently regain Zn 2ϩ and biological activity. Conversely, any model that calls for toxin to remain tightly bound to Zn 2ϩ during translocation would not be viable unless the translocation process could accommodate a somewhat bulky protein that retains at least some of its secondary and tertiary structure.
In the work that follows, both experimental studies and deduction have been used to gauge the likelihood that removal of Zn 2ϩ produces irreversible losses in botulinum toxin activity. This work then has been used to assess whether events that occur during the internalization step can impact events during the catalytic step. Botulinum neurotoxin type A was purified to homogeneity by procedures that have been described previously (10 -12) . Recombinant GST-SNAP-25 (ϳ50 kDa) was constructed and expressed according to published techniques. Murine SNAP-25 cDNA, pSNAP8.52, which was derived from a BALB/c strain brain Lambda cDNA library (13) kindly provided by Dr. Michael C. Wilson (Scripps Clinic, La Jolla, CA), was used as a polymerase chain reaction template. The polymerase chain reaction was carried out with primers 5Ј-TCT TGG ATC CGC CGA AGA CGC AGA CAT GC-3Ј and 5Ј-TCT TGG ATC CTT AAC CAC TTC CCA GCA TCT T-3Ј. A product of ϳ880 base pairs was digested with BamHI and ligated into pGEX-KG vector (14) . The resulting construct was sequenced to confirm that SNAP-25 cDNA had been inserted into pGEX-KG correctly. The transformation, expression of pGEX-KG/ SNAP-25 in bacteria, and purification of GST-SNAP-25 fusion protein were performed as described (15) .
Chelex ® 100 Treatment-All experiments were performed using buffers that were pretreated with Chelex ® 100 resin to remove trace amounts of cations such as Zn . Calculations based on manufacturer specifications indicated that 0.5 mg of Chelex ® 100 resin/liter of buffer should remove all trace cations from solution. The buffers used in these experiments were pretreated with a substantial excess of resin (5 g/liter) for 18 h at room temperature, and this was followed by filtration through a 0.2-m filter to remove the resin. Prior to use, all filters and labware were rinsed three times with Chelex ® 100-treated distilled water.
Sephadex G-25 Chromatography-For all experimental methods described below, 65 Zn associated with toxin was quantified using Sephadex G-25 chromatography followed by liquid scintillation counting. Columns were equilibrated by washing with a column buffer (50 mM NaPO 4 and 1 M NaCl, pH 6.8). Subsequently, 0.5-ml experimental samples of toxin were filtered through Sephadex G-25 columns, and ϳ0.5-ml (10-drop) fractions were collected. The samples were added to 3 ml of scintillation fluid, and the amount of radioactivity in the fractions was determined by liquid scintillation spectrometry. Labeled toxin eluted at void volume, and the radioactivity contained in the void-volume fractions was summed to determine the total amount of 65 Zn label associated with the toxin peak. Zinc Depletion-Zn 2ϩ depletion of toxin was carried out in 150 mM Tris-HCl buffer, pH 7.4, employing two steps. First, toxin was added to buffer containing 10 mM EDTA and EGTA (final concentrations) and incubated at 37°C for 1 h. Next, the toxin sample was dialyzed overnight at 3°C (18 h, minimum of two buffer changes) against this same buffer containing 10 mM EDTA and EGTA. After Zn 2ϩ depletion, the toxin sample was dialyzed into 50 mM sodium phosphate buffer, pH 7.0, that had been pretreated with Chelex ® 100 resin for 24 h (two buffer changes). Stripped (e.g. Zn 2ϩ -depleted) toxin was stored at 3°C in sterile vials that had been rinsed three times with Chelex ® -treated buffer, and it was used over a period of ϳ6 months. 65 Zn (2 ϫ 10 Ϫ7 M final concentration) as described above. The experiment with prelabeled toxin was initiated by warming to room temperature and adjusting the 500-l reaction mixture to a pH of ϳ4.00, ϳ5.00, or ϳ6.00 by the addition of the appropriate amount of 1 N HCl. Control reactions remained at pH 7.20. Experimental samples were incubated at room temperature for 30 min. For each sample, the Zn label associated with the toxin peak was determined. Synaptic Protein Preparation-Brain tissue was removed from mice and immediately immersed and homogenized in chilled buffer containing 255 mM sucrose, 1 mM EDTA, and 20 mM Hepes, pH. 7.4. The resulting suspension was homogenized with a Brinkmann homogenizer (E 2 M/Polytron, Norcross, GA) at a setting of ϳ4 -5 for ϳ1 min. The homogenates were centrifuged at 3,000 ϫ g for 5 min (SS-34 Rotor, Sorvall RC-5B Refrigerated Superspeed centrifuge). The resulting supernatant (S1) was centrifuged at 10,000 ϫ g for 10 min (same rotor and centrifuge). The second supernatant (S2) was centrifuged at 250,000 ϫ g for 70 min (T-865.1 Rotor, Sorvall Ultra 80 centrifuge). The resulting pellet (P3) was resuspended in 50 mM Hepes, pH 7.1. The protein concentration of P3 was determined using a Bio-Rad protein assay kit (Bio-Rad).
SNAP-25 Cleavage Assay-BoNT/A was assayed for endoprotease activity using either recombinant GST-SNAP-25 or synaptosomal SNAP-25. In both cases, an anti-C-terminal SNAP-25 antibody was used as a reagent in the immunodetection of enzyme activity (16) . When recombinant substrate was used, ϳ130 ng of GST-SNAP-25 was present in each reaction vessel; when synaptosomes were used, 7-10 g of P3 protein was added to each reaction. In the latter case, 1% N-octyl-␤-D-glucopyranoside was added to the reaction to permeabilize synaptosomes and expose SNAP-25.
Reactions were initiated by reducing BoNT/A (100 -200 nM) with dithiothreitol (8 mM) at room temperature for 30 min in cleavage buffer (50 mM Hepes, pH 7.1, plus 20 M ZnCl 2 ). When the assays were done with stripped toxin or chelators, auxiliary Zn 2ϩ was not added to the reactions mixtures. In most experiments, substrate was added to reduced toxin, and the reaction was allowed to proceed for 3 h at 37°C.
Immunodetection of Substrate Cleavage-Enzymatic cleavage reactions were terminated by adding an equal volume of 2ϫ sample buffer (125 mM Tris-HCl, pH 6.8, 1% SDS, 20% glycerol, 700 mM ␤-mercaptoethanol, and 0.01% bromphenol blue). The samples were denatured by incubating at 95°C with subsequent cooling and then separated in 10% polyacrylamide gels according to Laemmli (17) . SNAP-25 was transferred from gels to nitrocellulose membranes (0.45 m, Immobilon-NC and Fisher Scientific) and probed with anti-SNAP-25 C-terminal antibody at 1:10,000 dilution. Donkey anti-rabbit IgG conjugated with horseradish peroxidase was used as a secondary antibody at a dilution of 1:10,000. The antibody reaction was visualized by chemiluminescence (ECL Plus, Amersham Pharmacia Biotech) using x-ray film (Kodak Bio-Max).
Neuromuscular Preparations-Phrenic nerve hemidiaphragms were excised from mice as described previously (18, 19) . The tissues were suspended in physiological solution that was bubbled with 95% O 2 and 5% CO 2 and maintained at 35°C. Unless otherwise indicated, the physiological solution had the following composition: 137 mM NaCl, 5 mM KCl, 1.8 mM CaCl 2 , 1.0 mM MgSO 4 , 24 mM NaHCO 3 , 1.0 mM NaH 2 PO 4 , and 11 mM D-glucose. The solutions were supplemented with 0.01% gelatin as an auxiliary protein to diminish nonspecific inactivation of toxin. Phrenic nerves were stimulated continuously (0.5 Hz, 0.2-msec duration), and muscle twitch was recorded. Toxin-induced paralysis was measured as a 90% reduction in muscle twitch response to nerve stimulation.
RESULTS

Enzyme Activity and Neuromuscular Blocking Activity of Toxin after Incubation with Soluble
Chelators-Two paradigms were used to expose BoNT/A to soluble chelators. In the first, toxin was exposed for lengthy periods of time to a combination of EDTA and EGTA to strip Zn 2ϩ (see "Experimental Procedures"). In the second, toxin was incubated with TPEN for 60 min at room temperature before the assays. For both protocols, endoprotease activity was determined using recombinant substrate (GST-SNAP-25) or endogenous substrate (synaptosomal SNAP-25).
As shown in , the addition of micromolar amounts of Zn 2ϩ restored endoprotease activity. Samples of toxin that had been stripped of Zn 2ϩ with EDTA and EGTA or had been exposed transiently to TPEN were bioassayed for their abilities to produce neuromuscular blockade of phrenic nerve hemidiaphragm preparations (Fig. 2) . In both cases, treated toxin proved to be highly effective in blocking exocytosis. This result was obtained even though chelatortreated toxin was not exposed to exogenous Zn 2ϩ before its addition to tissues.
Effect of an Immobilized Chelator on Enzyme Activity and Neuromuscular Transmission-Experiments were done with Chelex ® , an immobilized chelator that cannot gain access to Zn 2ϩ within its coordination site in the toxin molecule but can bind free Zn 2ϩ in solution. The toxin was incubated with chelator as described under "Experimental Procedures" for 120 min at room temperature, after which the mixture was centrifuged to separate the components. Soluble toxin was then assayed for biological activity.
Interestingly, toxin exposed to Chelex ® possessed enzymatic activity and neuromuscular blocking activity comparable with those of native untreated toxin (e.g. Fig. 1, A-D, lane 2; Fig. 2 Experimental samples were incubated for 24 h at room temperature. Subsequently, the amount of exogenous radioactive Zn 2ϩ that replaced endogenous unlabeled Zn 2ϩ was determined.
As shown in Fig. 3A , there was concentration-dependent replacement of endogenous Zn 2ϩ . An exchange was evident even at 10 Ϫ7 M and was more pronounced at 10 Ϫ6 and 10
These results are consistent with the previously reported finding that the apparent K d for Zn 2ϩ at its binding site is ϳ60 -80 nM (20) .
In a subsequent set of experiments, the precise time course of Zn 2ϩ exchange was studied. This was done at a 65 Zn concentration of 2 ϫ 10 Ϫ7 M, which is on the linear portion of the concentration-effect curve shown in Fig. 3A . The results indicated that a steady state for exchange was attained within ϳ5-6 days, and the half-time for exchange was ϳ2-3 days (Fig.  3B) . This means that when studied in physiological buffer at pH 7.2, endogenous Zn 2ϩ can exchange with environmental Zn 2ϩ . The time course of this exchange is such as to make it possible for botulinum toxin molecules to undergo at least a fractional exchange of Zn 2ϩ during their lifetime (e.g. synthesis and release by bacteria, ingestion and absorption by victim, and binding, internalization, and onset of neuromuscular blockade).
Half 
FIG. 2. Zinc chelation and neuromuscular blockade.
Mouse phrenic nerve hemidiaphragms (group n ϭ 5 or more) were exposed to botulinum neurotoxin type A (1 ϫ 10 Ϫ11 M) that had been pretreated with a combination of EDTA and EGTA (10 mM each, E-E) or with TPEN (10 m, Ⅺ-Ⅺ). The amount of time necessary for chelator-treated toxin to produce neuromuscular blockade was compared with that of untreated toxin (f-f). The data revealed that the treated and untreated preparations were essentially identical in their abilities to cause paralysis.
results presented above and illustrated in Fig. 1 strongly suggest that stripped toxin can regain Zn 2ϩ and enzymatic activity. Furthermore, the in vitro toxicity experiments with phrenic nerve hemidiaphragm preparations indicate that stripped toxin can accumulate Zn 2ϩ rapidly (Fig. 2) . Therefore, experiments were done to quantify the rate at which Zn 2ϩ can be acquired.
Native toxin was stripped of endogenous Zn 2ϩ with a combination of EDTA and EGTA as described under "Experimental Procedures." Stripped toxin (1 ϫ 10 Ϫ7 M) was then incubated for various amounts of time with 65 Zn (2 ϫ 10 Ϫ7 M), and the rate of incorporation of exogenous zinc was monitored. The data, which are shown in Fig. 4 , indicate that the half-time for accumulation was ϳ6 min. This finding supports two conclusions: (a) the rate of Zn 2ϩ accumulation by stripped toxin is much greater than the rate of Zn 2ϩ exchange in native toxin, and (b) the rate of Zn 2ϩ accumulation by stripped toxin can easily account for the ability of this material to acquire exogenous Zn 2ϩ and block neuromuscular transmission (e.g. Fig. 2) . (Fig. 1) accounts for the finding that Chelex ® is not effective in abolishing toxicity (see above).
Effect of pH on Zn 2ϩ Retention-Botulinum toxin is not likely to encounter a chelator when it acts on neuromuscular junctions to paralyze transmission. However, there are ambient conditions encountered by the toxin that could produce a loss of Zn 2ϩ . The most notable of these is the fall in pH that is encountered when the toxin translocates from the lumen of the endosome to the cytosol. The fall in pH could produce a loss of Zn 2ϩ because low pH leads to protonation of histidine residues that coordinate Zn 2ϩ binding, low pH produces conformational changes that diminish Zn 2ϩ binding, or both. Therefore, experiments were done to quantify Zn 2ϩ retention at pH values (4.0 -7.2) that bridge the pK a for the imidazole side chain of histidine residues in proteins (6.1-6.4). Coincidentally, these pH values also bridge the range for those that induce conformational changes associated with toxin translocation.
Botulinum toxin was stripped of Zn 2ϩ as described above and loaded with 65 Zn. This material was then incubated with solutions of varying pH for 30 min at room temperature. When the levels of residual 65 Zn were quantified, the results (Fig. 5) showed that there was a significant loss of cation at a pH of 6.0. There was an additional loss of cation with further lowering of pH.
The exact pH at which toxin is induced to translocate from the endosome to the cytosol has not been determined. Nevertheless, the pH of primary endosomes is in the range of 6.2-6.3, and the pH of later stage endosomes is even lower (21) . Therefore, the fact that there is a significant loss of Zn 2ϩ at pH 6.0 suggests that, at least potentially, some endogenous cation could be lost during translocation. This could be caused by protonation of histidines, change in conformation, or both.
Pretreatment of Toxin and Tissue with Chelator (TPEN) and Subsequent Expression of Neuromuscular Blocking
Activity-As reported previously, pretreatment of toxin with a soluble chelator is not sufficient to cause the molecule to lose neuromuscular blocking activity (Ref. 8; see above). Stripped toxin can regain Zn 2ϩ from tissue stores and thus regain catalytic and neuromuscular blocking activity. A loss of activity is observed only if both toxin and tissue are pretreated with the chelator. Fig. 6 illustrates the results of an experiment in which native toxin and TPEN-pretreated toxin (10 M) were added either to control tissues or to TPEN-pretreated tissues (10 M). These data clearly show that native toxin and stripped toxin were Each q represents an average of two separate experiments with three replicates per experiment.
Zn 2ϩ and Botulinum Toxincomparable in their abilities to block neuromuscular transmission in control tissues (A and B). They also show that neither native toxin nor stripped toxin blocked transmission when added to tissues incubated in TPEN (A and B).
In a subsequent set of experiments, native toxin and stripped toxin were added to tissues pretreated with TPEN. After an elapsed time equivalent to that necessary for toxin to paralyze control tissues (i.e. Fig. 6A ), a molar excess of Zn 2ϩ (20 M) was added to preparations (C). It is noteworthy that (a) there was early onset of toxin action that eventually culminated in neuromuscular blockade, and (b) there was no significant difference between native toxin and stripped toxin in terms of rate of onset of blockade.
The results in Fig. 6C suggest that paralysis was caused by toxin that had already undergone productive internalization. To confirm this hypothesis, tissues were treated identically to that for tissues in C except that tissues were washed several times prior to the addition of Zn 2ϩ . Thus, there was no toxin left in solution for binding and later internalization. When tissues were washed free of extracellular toxin and then exposed to Zn 2ϩ , there was again a rapid onset of toxin action (D). Interestingly, there was no difference between tissues that were continuously exposed to toxin (C) and those that were washed to remove unbound toxin (D).
Rate of TPEN-induced Zn 2ϩ
Loss from Native Toxin-The data presented above show that soluble, but not immobilized, chelators can strip Zn 2ϩ from toxin. Stripped toxin has little ability to cleave substrate or to block neuromuscular transmission. However, toxin that regains Zn 2ϩ from tissue stores or from external sources regains biological activity.
The data in Fig. 6 , and particularly those on control toxin added to TPEN-pretreated tissue, presents a special circumstance. The fact that native toxin is rendered inactive when added to tissues incubated in TPEN suggests that a soluble chelator can strip the toxin in less time than that needed for the toxin to enter the nerve and begin cleaving substrate. This premise was tested by examining the rate of TPEN-induced loss of Zn 2ϩ . Samples of toxin (1 ϫ 10 Ϫ7 M) were stripped and reloaded with 65 Zn as described above. This material was incubated with TPEN (2 ϫ 10 Ϫ5 M) for varying lengths of time, after which zinc retention was measured. As shown in Fig. 7 , TPEN produced a significant loss of zinc within 20 min, and the loss continued to occur for at least 180 min.
These data provide qualitative support for the premise that TPEN can strip Zn 2ϩ during the brief interval when toxin is en route to its site of action. Indeed, the actual sequence of events in the tissue bath is likely to be even more dramatic than that suggested by Fig. 7 . For the Zn 2ϩ stripping experiment (e.g. Fig. 7 ) the ratio of chelator to toxin was ϳ200 (2 ϫ 10 Ϫ5 M TPEN; 1 ϫ 10 Ϫ7 M toxin). For the neuromuscular blocking experiments, the ratio was 2,000,000 (2 ϫ 10 Ϫ5 M TPEN; 1 ϫ A and B illustrate data in which native toxin was added either to control tissues (Ⅺ-Ⅺ) or to TPEN-pretreated tissues (10 M, f-f) and TPEN-pretreated toxin (10 M) was added either to control tissues (E-E) or TPEN-pretreated tissues (q-q). Note that the presence of TPEN in the tissue medium prevented the onset of toxin-induced neuromuscular blockade. C illustrates the data from an experiment with native toxin (f-f) and TPEN-pretreated toxin (as described above, q-q) were added to tissues incubated in TPEN (as described above). After an elapsed time of 120 min, which is approximately the amount of time for native toxin to paralyze control tissues, Zn 2ϩ (20 m, arrow) was added to tissues. The rate of the onset of paralysis for both sets of tissues was the same. D shows data from an experiment identical to that described in C except that tissues were washed three times before the addition of Zn 2ϩ . Again, the rate of the onset of paralysis for both sets of tissues was the same. In all experiments, the toxin concentration was 1 ϫ 10 Ϫ11 M. Group n in each experiment was five or greater.
Zn 2ϩ and Botulinum Toxin 27039 Ϫ11 M toxin). Therefore, the actual rate of Zn 2ϩ stripping while the toxin is en route to its site of action is likely to be greater than that shown in Fig. 7 .
DISCUSSION
Each of the three major steps in toxin action, binding, productive internalization, and intracellular metalloprotease activity, involves some element of complexity (see the Introduction). However, productive internalization may be the most complex of the three. This step is thought to involve at least seven distinguishable events: 1) penetration of the plasma membrane by the dichain holotoxin, 2) pH-induced change in toxin structure (viz. exposure of an occult hydrophobic domain), 3) insertion of the hydrophobic portion of the heavy chain into the endosome membrane, 4) reduction of the disulfide bond that links the heavy and light chains, 5) separation of the heavy and light chains, 6) translocation of the light chain from the lumen of the endosome to the cytosol, presumably via a heavy chain-mediated mechanism (viz. channel or cleft), and 7) restoration of light chain structure associated with movement from an acidic environment (endosome) to a more neutral environment (cytosol).
In addition, productive internalization may depend on events that occur during the prior, or binding, step. The pH-induced changes in structure and subsequent insertion of heavy chain into the endosome membrane may not occur or may occur with low efficiency if the toxin is not properly associated with its receptor. In other words, a toxin molecule that is free in solution may have difficulty inserting into the endosome membrane and initiating the process of translocation. Thus, productive internalization may depend on proper toxin association with the extracellular receptor during the prior binding step.
Interestingly, a recent series of apparently contradictory findings may point to another example of one step in toxin action, intracellular protease activity, depending on a prior step, productive internalization. Fu et al. (9) have reported that a loss of Zn 2ϩ by native botulinum toxin produces both irreversible loss of catalytic activity and irreversible changes in structure. If these claims are correct, they carry two important implications. First, botulinum toxin must not lose bound Zn 2ϩ during productive internalization. If it did lose the cation, the catalytic chain could not act intracellularly to block exocytosis. Second, the spontaneous loss of Zn 2ϩ by botulinum toxin in bacterial cultures, the environment, and the target organism must be very slow. Otherwise, the toxin would lose its ability to paralyze transmission even before reaching peripheral cholinergic nerve endings.
Various experiments were performed to test the premise that stripping toxin of Zn 2ϩ produces irreversible loss of catalytic activity. This involved the use of soluble and immobilized chelators. One of the soluble chelators, EDTA, was the same as that used by Fu et al. (9) , but the results were profoundly different. In the hands of the present investigators, both EDTA and TPEN caused virtually complete loss of enzyme activity as measured by the cleavage of recombinant substrate. When a molar excess of Zn 2ϩ was added to stripped preparations, there was rapid and substantial recovery of activity. These findings are in accord with those obtained by other investigators studying metal replacement in clostridial toxins (22, 23) . They are also in keeping with the findings of Ahmed and Smith (24) , who studied the loss and recovery of Zn 2ϩ by a recombinant light chain derived from botulinum toxin.
Experiments were also done with Chelex ® , an immobilized chelator, and the data were revealing. Even when incubated with toxin at a large molar excess, the chelator caused no detectable loss of enzyme activity within the same time frame that TPEN caused virtually complete loss. The major difference between the soluble chelator and the immobilized chelator is that the former can approach Zn 2ϩ within its coordination site and strip ion from toxin, whereas the latter remains remote from the coordination site and can bind only that Zn 2ϩ that has been released by toxin and is free in solution. The fact that Chelex ® did not cause a loss of enzyme activity suggests that there must be a slow rate of spontaneous loss of cation.
The next series of studies was designed to determine whether there is spontaneous turnover of bound Zn 2ϩ , and if so, the approximate time course of this phenomenon. The data indicate that the half-life for spontaneous exchange between bound Zn 2ϩ and radiolabeled Zn 2ϩ in the medium was 2-3 days. This rate of exchange is slow compared with the time course for toxin-induced neuromuscular blockade, but this is not the case when compared with the life span of a toxin molecule in its growth medium, the environment, and the body of a potential victim. The lifespan of a toxin molecule could easily exceed the half-life for bound Zn 2ϩ , and this in turn leads to one of three possible conclusions: 1) the toxin is in a constant and irreversible process of losing biological activity, because each molecule that loses a Zn 2ϩ ion irreversibly loses catalytic activity, 2) toxin that is in medium with exogenous zinc maintains biological activity, because the rate of exchange between The data discussed above on toxin treatment with EDTA or TPEN strongly indicate that the first possibility is not correct. Even when the toxin was completely stripped of Zn 2ϩ , it substantially regained biological activity when reloaded with zinc. The data also indicate that the second possibility has little biological relevance. When the toxin was maintained in a zincfree condition for a length of time much greater than that needed to reload stripped sites, there was still a substantial recovery of enzyme activity.
The data strongly favor the third possibility as reflected by the cell-free studies discussed above but also as reflected by studies on intact neuromuscular junctions. To begin with, the addition of native toxin and stripped toxin to phrenic nerve hemidiaphragm preparations produced equivalent paralysis times. As described in more detail elsewhere (8) , this result is likely because of stripped toxin regaining Zn 2ϩ from tissue stores. However, the results of a subsequent experiment may provide information of a more valuable nature. When stripped toxin was added to tissues immersed in medium with TPEN, there was no onset of paralysis. As expected, in the absence of bound Zn 2ϩ the toxin could not express catalytic activity. When a molar excess of exogenous Zn 2ϩ was added to these preparations, there was rapid onset of paralysis. This observation clearly shows that the toxin can go through a cycle of losing and regaining Zn 2ϩ and concomitantly losing and regaining enzymatic activity.
The latter experiment with TPEN and Zn 2ϩ on neuromuscular junctions warrants close inspection. The data in Fig. 6D show that exogenous Zn 2ϩ caused transmission to fail in preparations that had been washed free of unbound toxin. This suggests that exogenous Zn 2ϩ was activating toxin that was already in the cell interior. This must mean that botulinum toxin can bind and be internalized in the absence of Zn 2ϩ . To return to an earlier comment, binding and internalization are complex events, and many of these events involve substantial changes in conformation (e.g. insertion into the endosome membrane, separation of heavy and light chains, and translocation of light chain to the cytosol). Thus, the experiments in which stripped toxin regained Zn 2ϩ and regained catalytic activity after reaching the cytosol bear importantly on the analysis of structure-function relationships. The data strongly suggest that 1) any purported conformational changes in the botulinum toxin molecule that result from the removal of Zn 2ϩ are not of a nature or magnitude sufficient to interfere with conformational changes that are essential for productive internalization, and 2) the conformational changes associated with productive internalization do not have an effect on the toxin molecule of a nature or magnitude sufficient to block the uptake of Zn 2ϩ in a previously stripped molecule. These two conclusions, when taken together, mean that it is not absolutely essential for Zn 2ϩ to remain bound during productive internalization. If Zn 2ϩ is available from either endogenous or exogenous stores, the catalytic and therefore neuromuscular blocking properties of the toxin will be expressed.
There is an interesting and unanticipated implication of the observations on toxicity and tissue stores of Zn 2ϩ .
To be more precise, this is the second time that the structure-function relationships in the toxin molecule have been shown to have a permissive interaction with the physiology of the host organism. For many years, it has been known that botulinum toxin is synthesized as a relatively inactive single-chain molecule. Most clostridial organisms have a protease that nicks the single-chain precursor and converts it into an active dichain structure. However, even if the toxin is not nicked by the bacteria, it may still be quite potent. This is because when ingested, the unnicked molecule can be cleaved by proteases in the gut and converted to the active conformation.
The results with Zn 2ϩ described in the present manuscript reveal what seems to be a similar relationship between the toxin and host. Ordinarily the toxin molecule has a bound Zn 2ϩ that is essential for enzymatic activity. It has not yet been determined whether the toxin carries this bound Zn 2ϩ through all of the steps associated with blockade of exocytosis. If this does occur, then the bound Zn 2ϩ will support toxicity. However, even if it does not occur, the toxin can still be active. The stripped molecule can simply regain Zn 2ϩ from tissue stores and in the process assume the structure and express the activity needed for the blockade of exocytosis.
